| Brittany Spahr Fischtziur, | |
|
5402 W Aloha Dr, Diamondhead, MS 39525-3329 | |
| (228) 255-8889 | |
| (228) 255-0890 |
| Full Name | Brittany Spahr Fischtziur |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 5402 W Aloha Dr, Diamondhead, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467894436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 1115A (Alabama) | Secondary |
| 231H00000X | Audiologist | A4207 (Mississippi) | Primary |
| Provider Name | The Better Communication Clinic |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1891900163 PECOS PAC ID: 3971682402 Enrollment ID: O20080508000294 |
News Archive
Medgenics has announced that the latest, encouraging results of the Company's ongoing EPODURE Biopump Phase I/II Clinical Trial were presented at the 45th Conference of the Israeli Society of Nephrology and Hypertension, in Israel on March 27, 2009.
A team of researchers from the Hyperbaric Biomedical Research Laboratory at the University of South Florida (USF) doubled survival time in an aggressive metastatic cancer model using a novel combination of non-toxic dietary and hyperbaric oxygen therapies.
Detroit-area resident Muhammad Shahab pleaded guilty today for his role in organizing a Detroit-area home health care fraud scheme, announced Assistant Attorney General Lanny Breuer of the Criminal Division; U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office; and Special Agent in Charge Lamont Pugh III of the U.S. Department of Health and Human Services, Office of Inspector General's (HHS-OIG), Chicago Regional Office.
Using a novel, newly developed mouse model that mimics the development of Alzheimer's disease in humans, Johns Hopkins researchers say they have been able to determine that a one-two punch of major biological "insults" must occur in the brain to cause the dementia that is the hallmark of the disease.
Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Spahr Fischtziur, 5439 W Aloha Dr, Suite B, Diamondhead, MS 39525-3379 Ph: (228) 255-8889 | Brittany Spahr Fischtziur, 5402 W Aloha Dr, Diamondhead, MS 39525-3329 Ph: (228) 255-8889 |
News Archive
Medgenics has announced that the latest, encouraging results of the Company's ongoing EPODURE Biopump Phase I/II Clinical Trial were presented at the 45th Conference of the Israeli Society of Nephrology and Hypertension, in Israel on March 27, 2009.
A team of researchers from the Hyperbaric Biomedical Research Laboratory at the University of South Florida (USF) doubled survival time in an aggressive metastatic cancer model using a novel combination of non-toxic dietary and hyperbaric oxygen therapies.
Detroit-area resident Muhammad Shahab pleaded guilty today for his role in organizing a Detroit-area home health care fraud scheme, announced Assistant Attorney General Lanny Breuer of the Criminal Division; U.S. Attorney for the Eastern District of Michigan Barbara L. McQuade; Special Agent in Charge Andrew G. Arena of the FBI's Detroit Field Office; and Special Agent in Charge Lamont Pugh III of the U.S. Department of Health and Human Services, Office of Inspector General's (HHS-OIG), Chicago Regional Office.
Using a novel, newly developed mouse model that mimics the development of Alzheimer's disease in humans, Johns Hopkins researchers say they have been able to determine that a one-two punch of major biological "insults" must occur in the brain to cause the dementia that is the hallmark of the disease.
Results of a phase III clinical trial of the drug Enzalutamide, published yesterday in the New England Journal of Medicine, show the drug extends life by an average five months in the most advanced stages of prostate cancer.
› Verified 7 days ago
Dr. Virginia G Boyle, AUD CCC A SLP Audiologist Medicare: Medicare Enrolled Practice Location: 5439 W Aloha Dr, Ste B, Diamondhead, MS 39525 Phone: 228-255-8889 Fax: 228-255-0890 | |
The Better Communication Clinic Audiologist Medicare: Medicare Enrolled Practice Location: 5439 W Aloha Dr, Suite B, Diamondhead, MS 39525 Phone: 228-255-8889 Fax: 228-255-0890 |